VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
WVE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
WVEWave Life Sciences Ltd.
$3.78$727M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksWVEEarnings History

WVE logoWave Life Sciences Ltd. (WVE) Earnings History

Net Loss

13 years of earnings data (2013–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$202M
● Net Loss
TTM EPS (Diluted)
$-1.00
Per share, diluted
YoY EPS Growth
-72.9%
Declining
Net Margin
-478.3%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-504.1%
Gross Margin79.3%
Return on Equity-55.6%
Return on Assets-41.3%
Record Annual Net Income-$3MFY2013
Record Quarterly EPS$0.17Q4 2024
Consecutive Profitable Years0years
Q2 2026
Net Income-$69M
EPS (Diluted)$-0.34
YoY Growth-72.9%Declining
QoQ Growth-165.9%Declining

Loading earnings history...

Wave Life Sciences Ltd. (WVE) Earnings Overview

As of October 3, 2026, Wave Life Sciences Ltd. (WVE) reported trailing twelve-month net income of -$202M, reflecting -72.9% year-over-year growth. The company earned $-1.00 per diluted share over the past four quarters, with a net profit margin of -478.3%.

Looking at the long-term picture, WVE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3M in fiscal 2013.

Wave Life Sciences Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including SRPT (-$137M net income, -32.5% margin), IONS (-$565M net income, -40.4% margin), ARWR (-$320M net income, -0.2% margin), WVE has room to improve margins relative to the peer group. Compare WVE vs SRPT →

WVE Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
WVE logoWVECurrent
-$202M$-1.00-478.3%-55.6%-72.9%—
SRPT logoSRPT
-$137M$-1.30-32.5%-53.5%-404.7%
IONS logoIONS
-$565M$-3.41-40.4%-70.7%+21.7%
ARWR logoARWR
-$320M$-2.23-0.2%-0.5%+99.8%
NTLA logoNTLA
-$400M$-3.00-609.9%-53.5%+27.4%
BEAM logoBEAM
-$85M$-0.82-57.2%-8.1%+82.3%
Best in group
Lowest in group

WVE Historical Earnings Data (2013–2025)

13 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$204M-110.7%-$215M$-1.21-478.3%-504.1%
2024-$97M-68.7%-$110M$-0.70-89.6%-101.9%
2023-$58M+64.5%-$68M$-0.54-50.8%-60.0%
2022-$162M-32.4%-$163M$-2.05-4434.7%-4459.3%
2021-$122M+18.5%-$127M$-2.36-298.4%-310.1%
2020-$150M+22.6%-$153M$-3.82-746.7%-763.9%
2019-$194M-32.0%-$208M$-5.30-1211.5%-1303.4%
2018-$147M-43.7%-$160M$-5.06-1017.4%-1106.7%
2017-$102M-84.2%-$103M$-3.85-2754.7%-2769.4%
2016-$55M-188.5%-$55M$-2.43-3730.7%-3725.7%
2015-$19M-267.2%-$19M$-0.89-12631.6%-12696.1%
2014-$5M-57.6%-$5M$-0.25--
2013-$3M--$4M$-0.93--

Download Data

Export WVE earnings history in CSV or JSON format

Free sign-in required to download data

Consensus & Technical Research Suite
Open WVE Terminal

WVE Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

13+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

WVE — Frequently Asked Questions

Quick answers to the most common questions about buying WVE stock.

What is WVE earnings per share (EPS)?

WVE trailing twelve-month (TTM) diluted EPS is $-1.00, reflecting -72.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2013 to 2025 is available in the table on this page.

What is Wave Life Sciences Ltd.'s net income?

Wave Life Sciences Ltd. (WVE) trailing twelve-month net income is $-202M as of 2025. Earnings declined -72.9% year-over-year.

Is WVE profitable?

WVE is not currently profitable on a TTM basis, reporting a net loss of $-202M. Net margin is -478.3%. Investors should monitor for a return to profitability.

What is WVE's earnings growth rate?

WVE compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2025.

What are WVE's profit margins?

Wave Life Sciences Ltd. net profit margin is -478.3%, operating margin is -504.1%, and gross margin is +79.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -55.6%.

Is WVE growing earnings?

WVE earnings are declining — EPS fell -72.9% year-over-year. TTM net income dropped to $-202M. This contrasts with the 5-year CAGR of N/A.

What was WVE's best earnings year?

Wave Life Sciences Ltd.'s highest annual net income on record is $-3M, achieved in fiscal year 2013. Earnings history on this page spans 2013 to 2025 and includes all annual and quarterly figures.

What were WVE's earnings last quarter?

WVE's most recent reported quarter was Q2 2026. Net income was $-69M with diluted EPS of $-0.34. For a full breakdown of all quarters, see the quarterly earnings table on this page.

WVE Earnings Over Time (2013–2025)

Net income & EPS — annual and quarterly view